51 related articles for article (PubMed ID: 34371013)
21. A pan-cancer analysis revealing the role of LFNG, MFNG and RFNG in tumor prognosis and microenvironment.
Gong X; Zheng C; Jia H; Liu Y; Yang R; Chen Z; Pan Y; Li X; Liu Y
BMC Cancer; 2023 Nov; 23(1):1065. PubMed ID: 37932706
[TBL] [Abstract][Full Text] [Related]
22. Galactose differentially modulates lunatic and manic fringe effects on Delta1-induced NOTCH signaling.
Hou X; Tashima Y; Stanley P
J Biol Chem; 2012 Jan; 287(1):474-483. PubMed ID: 22081605
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of Manic fringe impedes angiogenesis and cell migration of renal carcinoma.
Cheng WK; Oon CE; Kaur G; Sainson RCA; Li JL
Microvasc Res; 2022 Jul; 142():104341. PubMed ID: 35157839
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the NOTCH1 Pathway by LUNATIC FRINGE Is Dominant over That of MANIC or RADICAL FRINGE.
Pennarubia F; Nairn AV; Takeuchi M; Moremen KW; Haltiwanger RS
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641486
[TBL] [Abstract][Full Text] [Related]
25. MFng is dispensable for mouse pancreas development and function.
Svensson P; Bergqvist I; Norlin S; Edlund H
Mol Cell Biol; 2009 Apr; 29(8):2129-38. PubMed ID: 19223466
[TBL] [Abstract][Full Text] [Related]
26. Nuclear and stromal expression of Manic fringe in renal cell carcinoma.
Cheng WK; Kaur G; Sjöberg E; Frödin M; Egevad L; Harmenberg U; Li JL; Oon CE
Exp Mol Pathol; 2021 Oct; 122():104667. PubMed ID: 34371013
[TBL] [Abstract][Full Text] [Related]
27. Fringe family genes and their modulation of Notch signaling in cancer.
Mugisha S; Di X; Disoma C; Jiang H; Zhang S
Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188746. PubMed ID: 35660646
[TBL] [Abstract][Full Text] [Related]
28. The role of hyaluronan in renal cell carcinoma.
Jin C; Zong Y
Front Immunol; 2023; 14():1127828. PubMed ID: 36936902
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma.
Harris WB
Mol Aspects Med; 2015 Nov; 45():47-54. PubMed ID: 26071853
[TBL] [Abstract][Full Text] [Related]
30. Telomere Length in Renal Cell Carcinoma: The Jekyll and Hyde Biomarker of Ageing of the Kidney.
Morais M; Dias F; Teixeira AL; Medeiros R
Cancer Manag Res; 2020; 12():1669-1679. PubMed ID: 32184670
[TBL] [Abstract][Full Text] [Related]
31. Impact of interaction networks of B cells with other cells on tumorigenesis, progression and response to immunotherapy of renal cell carcinoma: A review.
Wang YQ; Chen WJ; Li WY; Pan XW; Cui XG
Front Oncol; 2022; 12():995519. PubMed ID: 36465392
[TBL] [Abstract][Full Text] [Related]
32. Renal cell carcinoma and viral infections: A dangerous relationship?
Bersanelli M; Casartelli C; Buti S; Porta C
World J Nephrol; 2022 Jan; 11(1):1-12. PubMed ID: 35117975
[TBL] [Abstract][Full Text] [Related]
33. Advances in Renal Cell Carcinoma Drug Resistance Models.
Xiang Y; Zheng G; Zhong J; Sheng J; Qin H
Front Oncol; 2022; 12():870396. PubMed ID: 35619895
[TBL] [Abstract][Full Text] [Related]
34. Use of Circular RNAs in Diagnosis, Prognosis and Therapeutics of Renal Cell Carcinoma.
Osca-Verdegal R; Beltrán-García J; Górriz JL; Martínez Jabaloyas JM; Pallardó FV; García-Giménez JL
Front Cell Dev Biol; 2022; 10():879814. PubMed ID: 35813211
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
